Print
Sitemap
Search
About InterMune
Pipeline
Investors
News
Careers
Analyst Coverage
Annual Reports
Event Calendar
Information Request
Insider Trading
SEC Filings
Stock Information
Print Page
E-mail Page
RSS Feeds
E-mail Alerts
IR Contacts
Financial Tear Sheet
News
InterMune's press releases, conference calls, research presentations and archives.
Keyword Search
Submit
2012 |
2011
|
2010
|
2009
|
2008
Date
Title
04/26/12
InterMune Reports First Quarter 2012 Financial Results And Business Highlights
04/19/12
InterMune To Release First Quarter Financial Results On April 26
04/05/12
France's Transparency Commission (CT) Issues Favorable Opinion for Reimbursement of Esbriet® (pirfenidone)
03/27/12
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
03/15/12
Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA)
02/09/12
InterMune Reports Fourth Quarter and Full Year 2011 Financial Results and Business Highlights
02/09/12
InterMune Names Jonathan A. Leff, M.D., as Executive Vice President of Research and Development
02/02/12
InterMune to Release Fourth Quarter and Full Year Financial Results on February 9
01/05/12
InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights
01/05/12
InterMune to Present at J. P. Morgan Healthcare Conference
01/04/12
InterMune to Report Unaudited Fourth Quarter Esbriet® Revenue and Business Update on January 5
